Yi-Chin Lin Selected Research

Yi-Chin Lin Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 03/2011
4	Inflammation (Inflammations) 01/2017 - 12/2007
4	Coronary Artery Disease (Coronary Atherosclerosis) 06/2016 - 01/2012
2	Body Weight (Weight, Body) 11/2018 - 01/2007
2	Insulin Resistance 01/2018 - 05/2015
2	Neuroblastoma 04/2008 - 12/2007
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Bundle-Branch Block (Fascicular Block) 12/2019
1	Osteoporosis 11/2018
1	Heart Failure 11/2018
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2018
1	Atrophy 02/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Lung Neoplasms (Lung Cancer) 02/2016
1	Carcinoma (Carcinomatosis) 02/2016
1	Contact Dermatitis (Eczema, Contact) 05/2014
1	Communicable Diseases (Infectious Diseases) 03/2011
1	Alzheimer Disease (Alzheimer's Disease) 03/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2008
1	Intracranial Vasospasm 12/2007
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2007

Drug/Important Bio-Agent (IBA)

6	AntioxidantsIBA 01/2018 - 01/2010
4	EnzymesIBA 01/2018 - 01/2012
3	QuercetinIBA 06/2021 - 01/2014
3	coenzyme Q10 (CoQ10)IBA 11/2018 - 01/2012
3	LipidsIBA 01/2018 - 05/2015
3	Carnitine (L-Carnitine)FDA LinkGeneric 06/2016 - 08/2014
2	ubiquinolIBA 11/2018 - 01/2018
2	trichostatin A (A 300)IBA 02/2018 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 02/2018 - 02/2016
2	theasinensin AIBA 02/2018 - 02/2016
2	LipopolysaccharidesIBA 01/2017 - 04/2008
2	Phosphotransferases (Kinase)IBA 01/2017 - 05/2015
2	Oxidopamine (6 Hydroxydopamine)IBA 04/2008 - 12/2007
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	matriptase 2IBA 01/2022
1	Remifentanil (Ultiva)FDA Link 12/2019
1	Coffee FDA Link 11/2018
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 02/2018
1	3-hydroxyflavoneIBA 02/2018
1	HDL CholesterolIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Everolimus FDA Link 01/2017
1	MTOR InhibitorsIBA 01/2017
1	Kainic Acid (Kainate)IBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	GenisteinIBA 02/2016
1	Histones (Histone)IBA 02/2016
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 02/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	PalmitatesIBA 05/2015
1	Malondialdehyde (Propanedial)IBA 03/2015
1	C-Reactive ProteinIBA 03/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015
1	Inflammation MediatorsIBA 03/2015
1	InterleukinsIBA 03/2015
1	GoldIBA 05/2014
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 03/2011
1	VitaminsIBA 01/2010
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2010
1	Oxidants (Oxidizing Agents)IBA 01/2010
1	beta Carotene (Betacarotene)FDA Link 01/2010
1	Carotenoids (Carotene)IBA 01/2010
1	Plant ExtractsIBA 04/2008
1	catechol (pyrocatechol)IBA 04/2008
1	N- (4- O- glycerol- 3- methoxybenzyl)nonivamideIBA 12/2007
1	Calcitonin Gene-Related PeptideIBA 12/2007
1	Neuroprotective AgentsIBA 12/2007
1	TRPV Cation ChannelsIBA 12/2007
1	NeurotoxinsIBA 12/2007
1	Dietary PhosphorusIBA 01/2007

Therapy/Procedure

1	Intraperitoneal Injections 06/2021
1	Hemorrhoidectomy 12/2019
1	Oral Administration 05/2014